Immunovia's new lab staffed and operational after rapid implementation [Yahoo! Finance]
Onconetix, Inc. (ONCO)
Company Research
Source: Yahoo! Finance
cancer survival through early detection, today offers an update on its new lab in Research Triangle Park, USA. Immunovia announced on 29 April the company's plans to streamline its lab operations and move to Research Triangle Park (RTP), following the successful model development study of the next generation test. After taking occupancy on 21 May 2024 , Immunovia is today announcing that its lab is fully operational and staffed. All lab equipment is installed and validated. Systems for document control and quality management have been implemented. The new lab is also fully staffed following the hiring of two new scientists. The protein assays for Immunovia's next-generation test, developed in collaboration with Immunovia's partner Proteomedix, have been successfully transferred to the lab. The assays are performed on an ELISA platform and are faster, cheaper, and less-labor intensive than Immunovia's prior proprietary IMMray platform. Under the leadership and direction of Dr.
Show less
Read more
Impact Snapshot
Event Time:
ONCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCO alerts
High impacting Onconetix, Inc. news events
Weekly update
A roundup of the hottest topics
ONCO
News
- UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine [Yahoo! Finance]Yahoo! Finance
- Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director [Yahoo! Finance]Yahoo! Finance
- Immunovia Publishes Interim Report for January-March 2024 [Yahoo! Finance]Yahoo! Finance
- Immunovia Publishes Interim Report for January-March 2024 [Yahoo! Finance]Yahoo! Finance
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study [Yahoo! Finance]Yahoo! Finance
ONCO
Sec Filings
- 7/3/24 - Form 424B4
- 7/2/24 - Form EFFECT
- 6/25/24 - Form PRER14A
- ONCO's page on the SEC website